Author: Sweetlove Mel
Publisher: Adis International
ISSN: 1178-2595
Source: Pharmaceutical Medicine, Vol.26, Iss.2, 2012-04, pp. : 113-115
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Phase III ATENA Trial of Exemestane Discontinued
Pharmaceutical Medicine, Vol. 26, Iss. 1, 2012-02 ,pp. :
Phase III Trial of Eprotirome: Discontinued for Safety Concerns
Pharmaceutical Medicine, Vol. 26, Iss. 3, 2012-06 ,pp. :
Justification for Thai phase III HIV vaccine trial
Inpharma, Vol. 1, Iss. 1426, 2004-01 ,pp. :
Perampanel tolerability "acceptable" in phase III trial
Reactions Weekly, Vol. 1, Iss. 1384, 2012-01 ,pp. :
Phase III Trial of Dalcetrapib: Discontinued Due to Lack of Efficacy
Pharmaceutical Medicine, Vol. 26, Iss. 4, 2012-08 ,pp. :